<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-19T09:24:56Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2445/224959" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2445/224959</identifier><datestamp>2026-04-08T14:31:33Z</datestamp><setSpec>com_2072_1057</setSpec><setSpec>col_2072_478816</setSpec><setSpec>col_2072_478917</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Towards a glutathione-cleavable azobenzene linker for antibody–drug conjugates</dc:title>
   <dc:creator>Kapun, Mia</dc:creator>
   <dc:creator>Patel, Roshan</dc:creator>
   <dc:creator>Park, Mahri</dc:creator>
   <dc:creator>Pérez Areales, Francisco Javier</dc:creator>
   <dc:creator>Kostadinova, Kristina A.</dc:creator>
   <dc:creator>Wharton, Thomas</dc:creator>
   <dc:creator>Carroll, Jason S.</dc:creator>
   <dc:creator>Spring, David R.</dc:creator>
   <dc:subject>Fotofarmacologia</dc:subject>
   <dc:subject>Síntesi de pèptids</dc:subject>
   <dc:subject>Estrès oxidatiu</dc:subject>
   <dc:subject>Glutatió</dc:subject>
   <dc:subject>Photopharmacology</dc:subject>
   <dc:subject>Peptide synthesis</dc:subject>
   <dc:subject>Oxidative stress</dc:subject>
   <dc:subject>Glutathione</dc:subject>
   <dc:description>Herein we describe the development of a novel azobenzene-containing glutathione-cleavable linker for use in antibody–drug conjugates (ADCs). This linker demonstrated efficient payload release under elevated glutathione levels while maintaining stability in human plasma. An anti-HER2 ADC incorporating this linker exhibited potent &lt;em>in vitro&lt;/em> cytotoxicity and selective activity towards HER2-positive cell lines.</dc:description>
   <dc:date>2025-12-16T08:33:44Z</dc:date>
   <dc:date>2025-12-16T08:33:44Z</dc:date>
   <dc:date>2025-10-28</dc:date>
   <dc:date>2025-12-16T08:33:44Z</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>1359-7345</dc:identifier>
   <dc:identifier>https://hdl.handle.net/2445/224959</dc:identifier>
   <dc:identifier>762928</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Reproducció del document publicat a: https://doi.org/10.1039/D5CC05824D</dc:relation>
   <dc:relation>Chemical Communications, 2025, vol. 61, p. 18902-18905</dc:relation>
   <dc:relation>https://doi.org/10.1039/D5CC05824D</dc:relation>
   <dc:rights>cc-by (c)  Mia Kapun et al., 2025</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>4 p.</dc:format>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Royal Society of Chemistry</dc:publisher>
   <dc:source>Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)</dc:source>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>